Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 19, 2021 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 2,582 | $3.81 | 332,552 |
| Jan 19, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 64,626 | $4.00 | 351,915 |
| Jan 19, 2021 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Open market or private sale of non-derivative or derivative security | 11,657 | $3.81 | 340,258 |
| Jan 19, 2021 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 3,844 | $3.81 | 373,918 |
| Dec 24, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $3.79 | 115,967 |
| Dec 18, 2020 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Other acquisition or disposition | -- | -- | 1,538 |
| Dec 16, 2020 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Other acquisition or disposition | -- | -- | 11,840 |
| Dec 16, 2020 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 150,899 | $4.70 | 377,762 |
| Dec 14, 2020 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 25,696 | $5.00 | 335,134 |
| Dec 10, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
| Dec 10, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Nov 20, 2020 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Other acquisition or disposition | -- | -- | 1,538 |
| Nov 18, 2020 |
Director, CEO & President
|
Director, CEO & President | Form 4 | Open market or private sale of non-derivative or derivative security | 162,473 | $4.13 | 528,661 |
| Nov 09, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $3.56 | 306,424 |
| Nov 09, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Other acquisition or disposition | -- | -- | 7,226 |
| Nov 09, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $3.78 | 105,967 |
| Nov 06, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 7,025 | $3.50 | 301,424 |
| Sep 16, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,000 | $4.24 | 95,967 |
| Aug 28, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | $4.08 | 94,967 |
| Aug 12, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 250 | $3.71 | 248,769 |
| Aug 12, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Other acquisition or disposition | -- | -- | 6,250 |
| Aug 11, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 294 | $4.03 | 249,019 |
| Jul 09, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 13,881 | $3.36 | 249,313 |
| Jul 09, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Other acquisition or disposition | -- | -- | 6,250 |
| Jun 30, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,000 | $3.21 | 74,967 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.